Skip to content

Author

Andrea L. Cox

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

IL-6 Blockade with Clazakizumab is Associated with Low Myeloid Cell Activation and Increased Type 2 Immune Responses in Non-survivors of COVID-19.

BACKGROUND IL-6 inhibitors have been associated with reduced mortality in severe COVID-19 in randomized clinical trials, but the comprehensive immunological impact of IL-6 blockade in the setting of an acute viral infection is poorly understood. METHODS To gain insight into the systemic immune response to IL-6 inhibi...

Laila Stoddart, T. Johnston, Wei-Qiang Zhou et al. · 0 citations
Open access Sep 2026

Balancing lipid synthesis and oxidation promotes B cell response to vaccination during immunosuppression.

Pharmacologic immunosuppression is essential for preventing organ rejection and controlling autoimmunity, but profoundly impairs humoral immunity, increasing the risk of vaccine failure and infection. The mechanisms by which immunosuppressive therapies disrupt human B cell responses remain poorly defined. Here, we iden...

Elizabeth A. Thompson, Alexis Figueroa, Katerina Roznik et al. · 0 citations
Open access Sep 2026

An altered B cell compartment distinguishes low antibody responders among people with HIV

Chronic HIV infection can leave persistent immune dysregulation despite effective antiretroviral therapy (ART), but how this altered immune landscape affects antibody induction and durability after antigen exposure remains unclear. We used SARS-CoV-2 infection and vaccination as a model of humoral immunity to a novel a...

Karli R. Redinger, Samuel B. Warner, A. Jamal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.